SciVision Biotech Inc.

TWSE:1786 株式レポート

時価総額：NT$6.6b

SciVision Biotech 配当と自社株買い

配当金 基準チェック /36

SciVision Biotech配当を支払う会社であり、現在の利回りは2.68%で、収益によって十分にカバーされています。

主要情報

2.7%

配当利回り

n/a

バイバック利回り

総株主利回りn/a
将来の配当利回りn/a
配当成長13.5%
次回配当支払日n/a
配当落ち日n/a
一株当たり配当金NT$2.500
配当性向79%

最近の配当と自社株買いの更新

SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's

Jul 22
SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's

SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

Jun 28
SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

Recent updates

Is Now The Time To Put SciVision Biotech (TWSE:1786) On Your Watchlist?

Oct 11
Is Now The Time To Put SciVision Biotech (TWSE:1786) On Your Watchlist?

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Aug 30
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's

Jul 22
SciVision Biotech's (TWSE:1786) Upcoming Dividend Will Be Larger Than Last Year's

SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

Jun 28
SciVision Biotech (TWSE:1786) Has Announced That It Will Be Increasing Its Dividend To NT$2.50

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Jun 14
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Jun 04
SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Apr 20
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Apr 02
SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Mar 15
Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Feb 25
Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Feb 05
Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Jan 18
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

Jan 01
Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Dec 14
SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Nov 25
Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

決済の安定と成長

配当データの取得

安定した配当: 1786は 10 年未満配当金を支払っており、この間、支払額は 変動性 が高かった。

増加する配当: 1786の配当金は増加していますが、同社は9年間しか配当金を支払っていません。

配当利回り対市場

SciVision Biotech 配当利回り対市場
1786 配当利回りは市場と比べてどうか？
セグメント配当利回り
会社 (1786)2.7%
市場下位25% (TW)1.7%
市場トップ25% (TW)4.5%
業界平均 (Medical Equipment)2.9%
アナリスト予想 (1786) (最長3年)n/a

注目すべき配当: 1786の配当金 ( 2.68% ) はTW市場の配当金支払者の下位 25% ( 1.73% ) よりも高くなっています。

高配当: 1786の配当金 ( 2.68% ) はTW市場の配当金支払者の上位 25% ( 4.45% ) と比較すると低いです。

株主への利益配当

収益カバレッジ: 現在の配当性向（ 79% ）では、 1786の支払いは利益によってカバーされています。

株主配当金

キャッシュフローカバレッジ: 現在の現金配当性向（ 78.8% ）では、 1786の配当金はキャッシュフローによって賄われています。

高配当企業の発掘

7D

1Y

7D

1Y

7D

1Y